| Literature DB >> 33841500 |
Vaishali Chakravarty1, Libi Anandi1, K A Ashiq1, K Abhijith1, Rintu Umesh1, Mayurika Lahiri1.
Abstract
Lipid species are known to have various biological functions owing to their structural differences, and each of them possesses a specific role to play depending upon their location and distribution in the cell. Some of these lipids interact with proteins on the cell membrane and acts as second messengers. The level of lipid mediators is generally maintained in the cell by feedback mechanisms; however, their improper degradation or enhanced production leads to their accumulation in the tumor microenvironment and disturbs the homeostasis of the cell. Platelet activating factor (PAF) is a known phospholipid mediator secreted upon immunological challenges by platelets, neutrophils, basophils, and macrophages. PAF, as a potent inflammatory molecule, is well studied, and its role in various cancers and cardiovascular diseases has also been investigated. Interestingly, increased levels of PAF have been found in the blood plasma of smokers, and breast cancer cells have shown the accumulation of PAF in presence of cigarette smoke extract. This accumulation was found to increase tumor cell motility that in turn could promote metastasis. Beyond this, however, the effect of PAF on tumorigenesis has not yet been well explored. Here, we show that the continuous exposure of 3D breast acinar cultures to PAF resulted in the activation of various oncogenic signaling pathways leading to transformation. We also found that the presence of PAF in the micro-environment increased the expression of PAF receptor (PAF-R), which corroborated with the higher expression of PAF-R detected in some epithelial cancers, as per literature. Thus, this study impresses on the fact that the presence of PAF alters the cellular microenvironment and eventually triggers irreversible effects that can cumulatively lead to transformation.Entities:
Keywords: breast cancer; epithelial-mesenchymal transition; platelet activating factor; polarity; transformation
Year: 2021 PMID: 33841500 PMCID: PMC8027472 DOI: 10.3389/fgene.2021.634938
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Figure 1PAF treatment on 3D cultures of MCF10A leads to increased proliferation. MCF10A cells grown as 3D cultures for 20 days treated with and without PAF (200 nM) were immunostained with the proliferation marker, Ki67. (A) Representative image showing hyperproliferation in PAF-treated acini. The data are from N = 5 set of experiments. (B) Protein lysates from 20-day cultures were immunoblotted for Ki67. The values represent the relative expression of Ki67 normalized to GAPDH.
Figure 2PAF treatment alters acinar polarity and leads to the disruption of cell-cell junctions. PAF-treated 20 days 3D cultures of MCF10A were immunostained with polarity and cell-cell junction markers. Nucleus is stained with Hoecsht 33,258 (blue). (A) Immunostained images of α6-integrin (green) marks the basal polarity (N = 4). (B) Immunostained images of LamininV (green) marks the basement membrane of the acini (N = 4). (C) Immunostained images of GM130 (green) marks apical polarity (N = 3). (D) Immunostained images of β-catenin (red) marks the cell-cell junctions. (E) Dissociated cells of control and PAF-treated acini immunostained with E-cadherin (green), a cell-cell junction marker and the image is a representative of the phenotype (N = 3). (F) Dissociated cells of control and PAF treated acini immunostained with β-catenin (red), a cell-cell junction marker and the image is a representative of the diffused phenotype (N = 3). (G) Median fluorescent intensity of E-cadherin line profile showing loss phenotype. (H) FWHM profile of β-catenin line profile showing diffused phenotype. The phenotypes are quantified from N > 3 set independent experiments. Statistical analysis was performed for (H) using Mann Whitney U test; *****p < 0.0001.
Figure 3PAF treatment induces partial epithelial-mesenchymal transition (EMT)-like phenotype. MCF10A cells grown for 20 days on Matrigel™ treated with and without 200 nM PAF immunostained and immunoblotted with EMT markers. (A) PAF-treated acini showed upregulated vimentin expression (green). (B) Box plot depicts the acinar fluorescence (CTCF) of vimentin (N = 4). (C) 20-day 3D culture lysates of control and PAF immunoblotted for various EMT markers. The values represent fold change with respect to control and normalized to GAPDH (N = 3). (D) mRNA expression analysis done for various EMT markers using RNA lysates. The values represent fold change with respect to control and normalized to β2M (N = 3). (E) Phase contrast images of dissociated cells of PAF treated acini grown as 2D cultures showed a mesenchymal phenotype. (F) Dissociated cells of control and PAF, seeded on rat tail collagen type1 containing DQ™ collagen type1 and fluorescence intensity captured on SP8 confocal microscope (Leica, Germany). (G) Quantification of the DQ fluorescence per cell (n = 150). (H) Coomassie-stained gel showing gelatinase activity using conditioned media from 3D cultures. The values represent fold change with respect control and normalized to GAPDH. Statistical analysis was performed for (A) and (F) using Mann Whitney U test; ****p < 0.0001.
Figure 4Effect of PAF on anchorage independent growth of MCF10A cells and activation of the PI3K/AKT pathway. Dissociated cells were grown on soft agar and stained with MTT to visualize colonies formed and the pathway for PAF induced transformation. (A) Phase contrast images showing MTT stained colonies grown on soft agar. (B) Quantification of the number of colonies formed on soft agar (N = 3). (C) Transcript level of PAF-R. The values represent fold change with respect to control and normalized to β2M (N = 3). (D) Western blot indicating activation of AKT through PAF-R. The values represent fold change with respect to control and normalized to GAPDH (N = 3). (E) Pathway showing the activation of AKT downstream of PAF-R activation.